Recombinant Rat PPAR-α protein (His tag)

A DNA sequence encoding the Rat PPAR-α protein (P37230) (Ser 280-Leu 433) was expressed with a N-His tag.

Introducing the Recombinant Rat PPAR-α Protein (HIS TAG), a meticulously engineered product designed to cater to the needs of scientific research and experimentation. This protein, derived from the rat species, is a result of advanced recombinant technology, ensuring utmost purity and quality.

The Recombinant Rat PPAR-α Protein (HIS TAG) boasts a unique feature of a Histidine (HIS) tag, which facilitates easy purification and detection. This tag enables researchers to conveniently isolate and identify the protein, streamlining the experimental process and enhancing efficiency.

With its exceptional purity and stability, the Recombinant Rat PPAR-α Protein (HIS TAG) guarantees reliable and reproducible results, making it an indispensable tool for various applications in the field of molecular biology, biochemistry, and pharmacology. Its high affinity for binding to specific DNA sequences allows for comprehensive investigations into gene regulation and transcriptional activity.

Furthermore, this protein exhibits remarkable versatility, enabling researchers to explore its potential in drug discovery, target identification, and validation studies. Its compatibility with a wide range of experimental techniques, such as gel shift assays, protein-protein interaction studies, and reporter gene assays, further amplifies its utility and value.

The Recombinant Rat PPAR-α Protein (HIS TAG) is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. It is supplied in a lyophilized form, preserving its integrity and extending its shelf life.

In summary, the Recombinant Rat PPAR-α Protein (HIS TAG) stands as an exceptional product, meticulously crafted to meet the demands of scientific research. Its purity, stability, and versatility make it an invaluable asset for researchers seeking to unravel the intricacies of gene regulation and explore novel therapeutic avenues.